Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (1): 256-264.doi: 10.13481/j.1671-587X.20220133
• Review • Previous Articles Next Articles
-
Received:2021-08-17Online:2022-01-28Published:2022-01-17
CLC Number:
- R758.41
Cite this article
share this article
| 1 | FRISOLI M L， ESSIEN K， HARRIS J E. Vitiligo： mechanisms of pathogenesis and treatment［J］. Annu Rev Immunol， 2020， 38： 621-648. |
| 2 | NARAYAN V S， UITENTUIS S E， LUITEN R M， et al. Patients’perspective on current treatments and demand for novel treatments in vitiligo［J］. J Eur Acad Dermatol Venereol， 2021， 35（3）： 744-748. |
| 3 | NIU C， AISA H A. Upregulation of melanogenesis and tyrosinase activity： potential agents for vitiligo［J］. Molecules， 2017， 22（8）： E1303. |
| 4 | CHEN J R， LI S L， LI C Y. Mechanisms of melanocyte death in vitiligo［J］. Med Res Rev， 2021， 41（2）： 1138-1166. |
| 5 | BOUKHEDOUNI N， MARTINS C， DARRIGADE A S，et al. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo［J］.JCI Insight，2020，5（11）：e133772. |
| 6 | WU X Y， YANG Y W， XIANG L H， et al. The fate of melanocyte： Mechanisms of cell death in vitiligo［J］. Pigment Cell Melanoma Res， 2021， 34（2）： 256-267. |
| 7 | BERGQVIST C， EZZEDINE K. Vitiligo： a focus on pathogenesis and its therapeutic implications［J］. J Dermatol， 2021， 48（3）： 252-270. |
| 8 | SINGH M， KOTNIS A， JADEJA S D， et al. Cytokines： the Yin and Yang of vitiligo pathogenesis［J］. Expert Rev Clin Immunol， 2019， 15（2）： 177-188. |
| 9 | FRĄCZEK A， OWCZARCZYK-SACZONEK A， PLACEK W. The role of TRM cells in the pathogenesis of vitiligo-A review of the current state-of-the-art［J］. Int J Mol Sci， 2020， 21（10）： E3552. |
| 10 | SENESCHAL J， BONIFACE K， D’ARINO A， et al. An update on vitiligo pathogenesis［J］. Pigment Cell Melanoma Res， 2021， 34（2）： 236-243. |
| 11 | SEARLE T， AL-NIAIMI F， ALI F R. Vitiligo： an update on systemic treatments［J］. Clin Exp Dermatol， 2021， 46（2）： 248-258. |
| 12 | LI S L， ZHU G N， YANG Y Q， et al. Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes［J］. J Allergy Clin Immunol， 2017， 140（1）： 177-189.e9. |
| 13 | ABDALLAH M， EL-MOFTY M， ANBAR T， et al. CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity： a multicenter cross-sectional study［J］. Pigment Cell Melanoma Res， 2018， 31（2）： 330-336. |
| 14 | RICHMOND J M， STRASSNER J P， RASHIGHI M， et al. Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo［J］. J Invest Dermatol， 2019， 139（4）： 769-778. |
| 15 | JAENISCH R， YOUNG R. Stem cells， the molecular circuitry of pluripotency and nuclear reprogramming［J］. Cell， 2008， 132（4）： 567-582. |
| 16 | 黄梁江， 陈 红. 干细胞的临床研究与转化［J］. 内科急危重症杂志， 2020， 26（2）： 104-108. |
| 17 | PRAVEEN KUMAR L， KANDOI S， MISRA R，et al. The mesenchymal stem cell secretome： a new paradigm towards cell-free therapeutic mode in regenerative medicine［J］. Cytokine Growth Factor Rev， 2019， 46： 1-9. |
| 18 | BOCHON B， KOZUBSKA M， SURYGAŁA G， et al. Mesenchymal stem cells－potential applications in kidney diseases［J］. Int J Mol Sci， 2019， 20（10）： 2462. |
| 19 | OWCZARCZYK-SACZONEK A， WOCIÓR A， PLACEK W， et al. The use of adipose-derived stem cells in selected skin diseases （vitiligo， alopecia， and nonhealing wounds）［J］. Stem Cells Int， 2017， 2017： 4740709. |
| 20 | ZHANG P， KLING R E， RAVURI S K， et al. A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration［J］. J Tissue Eng， 2014， 5： 2041731414556850. |
| 21 | ANDERI R， MAKDISSY N， AZAR A， et al. Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata［J］. Stem Cell Res Ther， 2018， 9（1）： 141. |
| 22 | PAGANELLI A， KALECI S， BENASSI L， et al. Mesenchymal stem cells and psoriasis： State of the art and future perspectives［J］.Dermatol Ther，2020，33（2）：e13247. |
| 23 | HEO J R， HWANG K A， KIM S U， et al. A potential therapy using engineered stem cells prevented malignant melanoma in cellular and xenograft mouse models［J］. Cancer Res Treat， 2019， 51（2）： 797-811. |
| 24 | CIPRIANI P， DI BENEDETTO P， LIAKOULI V，et al.Mesenchymal stem cells （MSCs） from scleroderma patients （SSc） preserve their immunomodulatory properties although senescent and normally induce T regulatory cells （Tregs） with a functional phenotype： implications for cellular-based therapy［J］. Clin Exp Immunol， 2013， 173（2）： 195-206. |
| 25 | XU J Y. Therapeutic applications of mesenchymal stem cells for systemic lupus erythematosus［J］. Adv Exp Med Biol， 2018， 1089： 73-85. |
| 26 | YANG K， QIU W， GU P R， et al. Regeneration of mouse skin melanocyte stem cells in vivo and in vitro ［J］. Methods Mol Biol， 2019， 1879： 267-284. |
| 27 | LI H R， HOU L. Regulation of melanocyte stem cell behavior by the niche microenvironment［J］. Pigment Cell Melanoma Res， 2018， 31（5）： 556-569. |
| 28 | LEE J H， FISHER D E. Melanocyte stem cells as potential therapeutics in skin disorders［J］. Expert Opin Biol Ther， 2014， 14（11）： 1569-1579. |
| 29 | LEI T C， HEARING V J. Deciphering skin re-pigmentation patterns in vitiligo： an update on the cellular and molecular events involved［J］. Chin Med J （Engl）， 2020， 133（10）： 1231-1238. |
| 30 | GUO H Y， XING Y Z， LIU Y X， et al. Wnt/β-catenin signaling pathway activates melanocyte stem cells in vitro and in vivo ［J］. J Dermatol Sci， 2016， 83（1）： 45-51. |
| 31 | INFARINATO N R， STEWART K S， YANG Y H， et al. BMP signaling： at the gate between activated melanocyte stem cells and differentiation［J］. Genes Dev， 2020， 34（23/24）： 1713-1734. |
| 32 | REGAZZETTI C， JOLY F， MARTY C， et al. Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway： a promising target for repigmenting vitiligo patients［J］. J Invest Dermatol， 2015， 135（12）： 3105-3114. |
| 33 | YARDMAN-FRANK J M， FISHER D E. Skin pigmentation and its control： From ultraviolet radiation to stem cells［J］. Exp Dermatol， 2021， 30（4）： 560-571. |
| 34 | OCAMPO-GARZA J， SALINAS-SANTANDER M， WELSH O， et al. Expression of melanocortin 1 receptor before and after narrowband UVB phototherapy treatment in patients with stable vitiligo： a prospective study［J］. Exp Ther Med， 2020， 19（3）： 1649-1654. |
| 35 | BIRLEA S A， GOLDSTEIN N B， NORRIS D A. Repigmentation through melanocyte regeneration in vitiligo［J］. Dermatol Clin， 2017， 35（2）： 205-218. |
| 36 | OKAMOTO N， AOTO T， UHARA H， et al. A melanocyte： melanoma precursor niche in sweat glands of volar skin［J］. Pigment Cell Melanoma Res， 2014， 27（6）： 1039-1050. |
| 37 | FRIEDENSTEIN A J. Precursor cells of mechanocytes［M］//International review of cytology. Amsterdam： Elsevier， 1976： 327-359. |
| 38 | KESHTKAR S， AZARPIRA N， GHAHREMANI M H. Mesenchymal stem cell-derived extracellular vesicles： novel frontiers in regenerative medicine［J］. Stem Cell Res Ther， 2018， 9（1）： 63. |
| 39 | MEI X Y， SUN Y， WU Z W， et al. In vitro -induced differentiation of bone marrow mesenchymal stem cells into melanocytes［J］. Cell Biol Int， 2015， 39（7）： 824-833. |
| 40 | ESQUIVEL D， MISHRA R， SRIVASTAVA A. Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo： a review［J］. Curr Pharm Des， 2020， 26（37）： 4815-4821. |
| 41 | KIM D S， JANG I K， LEE M W， et al. Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-Γ［J］. EBioMedicine， 2018， 28： 261-273. |
| 42 | LANZA C， MORANDO S， VOCI A， et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo ［J］. J Neurochem， 2009， 110（5）： 1674-1684. |
| 43 | ZHANG F， PENG W X， ZHANG J， et al. New strategy of bone marrow mesenchymal stem cells against oxidative stress injury via Nrf2 pathway： oxidative stress preconditioning［J］. J Cell Biochem， 2019， 120（12）： 19902-19914. |
| 44 | ZHU L F， LIN X， ZHI L， et al. Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo［J］. Stem Cell Res Ther， 2020， 11（1）： 26. |
| 45 | ZUK P A， ZHU M， MIZUNO H， et al. Multilineage cells from human adipose tissue： implications for cell-based therapies［J］. Tissue Eng， 2001， 7（2）： 211-228. |
| 46 | MAZINI L， ROCHETTE L， HAMDAN Y， et al. Skin immunomodulation during regeneration： emerging new targets［J］. J Pers Med， 2021， 11（2）： 85. |
| 47 | HORINOUCHI C D， BARISÓN M J， ROBERT A W， et al. Influence of donor age on the differentiation and division capacity of human adipose-derived stem cells［J］. World J Stem Cells， 2020， 12（12）： 1640-1651. |
| 48 | ZAVALA G， SANDOVAL C， MEZA D， et al. Differentiation of adipose-derived stem cells to functional CD105neg CD73low melanocyte precursors guided by defined culture condition［J］. Stem Cell Res Ther， 2019， 10（1）： 249. |
| 49 | GENTILE P， GARCOVICH S. Adipose-derived mesenchymal stem cells （AD-MSCs） against ultraviolet （UV） radiation effects and the skin photoaging［J］. Biomedicines， 2021， 9（5）： 532. |
| 50 | EL-BADAWY A， AMER M， ABDELBASET R，et al. Adipose stem cells display higher regenerative capacities and more adaptable electro-kinetic properties compared to bone marrow-derived mesenchymal stromal cells［J］. Sci Rep， 2016， 6： 37801. |
| 51 | KIM J Y， PARK C D， LEE J H， et al. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes［J］. Acta Derm Venereol， 2012， 92（1）： 16-23. |
| 52 |
SALEH A A， ABDEL SALAM O H， METWALLY H G， et al. Comparison treatment of vitiligo by co-culture of melanocytes derived from hair follicle with adipose-derived stem cells with and without NB-UVB［J］. Pigmentary Disorders， 2017， 4（1）. DOI：10.4172/2376-0427.1000256 .
doi: 10.4172/2376-0427.1000256 |
| 53 | VIZOSO F J， EIRO N， CID S， et al. Mesenchymal stem cell secretome： toward cell-free therapeutic strategies in regenerative medicine［J］. Int J Mol Sci， 2017， 18（9）： E1852. |
| 54 | CHOI E W， SEO M K， WOO E Y， et al. Exosomes from human adipose-derived stem cells promote proliferation and migration of skin fibroblasts［J］. Exp Dermatol， 2018， 27（10）： 1170-1172. |
| 55 | XU R， GREENING D W， ZHU H J， et al. Extracellular vesicle isolation and characterization：toward clinical application［J］.Clin Invest，2016，126（4）：1152-1162. |
| 56 | BELLEI B， MIGLIANO E， TEDESCO M， et al. Adipose tissue-derived extracellular fraction characterization： biological and clinical considerations in regenerative medicine［J］. Stem Cell Res Ther， 2018， 9（1）： 207. |
| 57 | CAI Y， LI J Y， JIA C S， et al. Therapeutic applications of adipose cell-free derivatives： a review［J］. Stem Cell Res Ther， 2020， 11（1）： 312. |
| 58 | BELLEI B， PAPACCIO F， FILONI A， et al. Extracellular fraction of adipose tissue as an innovative regenerative approach for vitiligo treatment［J］. Exp Dermatol， 2019， 28（6）： 695-703. |
| 59 | PAINO F， RICCI G， DE ROSA A， et al. Ecto-mesenchymal stem cells from dental pulp are committed to differentiate into active melanocytes［J］. Eur Cell Mater， 2010， 20： 295-305. |
| 60 | TSUCHIYAMA K， WAKAO S， KURODA Y， et al. Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring （muse） cells， distinct stem cells in human fibroblasts［J］. J Invest Dermatol， 2013， 133（10）： 2425-2435. |
| 61 | YAMAUCHI T， YAMASAKI K， TSUCHIYAMA K， et al. A quantitative analysis of multilineage-differentiating stress-enduring （Muse） cells in human adipose tissue and efficacy of melanocytes induction［J］. J Dermatol Sci， 2017， 86（3）： 198-205. |
| 62 | FANG D， LEISHEAR K， NGUYEN T K， et al. Defining the conditions for the generation of melanocytes from human embryonic stem cells［J］. Stem Cells， 2006， 24（7）： 1668-1677. |
| 63 | WU D C， BOYD A S， WOOD K J. Embryonic stem cell transplantation： potential applicability in cell replacement therapy and regenerative medicine［J］. Front Biosci， 2007， 12： 4525-4535. |
| 64 | GLEDHILL K， GUO Z Y， UMEGAKI-ARAO N，et al. Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells［J］. PLoS One， 2015， 10（8）： e0136713. |
| 65 | 李遇梅， 张怡萱， 刘莉萍. 诱导性多功能干细胞在皮肤科研究与应用的进展［J］. 中华皮肤科杂志， 2019， 52（7）： 445-449. |
| 66 | 伍婧玥， 李 敏， 王 刚， 等. 毛囊干细胞的应用领域［J］. 中华细胞与干细胞杂志（电子版）， 2020， 10（6）： 359-363. |
| 67 | YASHIRO M， MII S， AKI R， et al. From hair to heart： nestin-expressing hair-follicle-associated pluripotent （HAP） stem cells differentiate to beating cardiac muscle cells［J］. Cell Cycle， 2015， 14（14）： 2362-2366. |
| 68 | TOTANI A， AMIN H， BACCHI S， et al. Vitiligo following stem-cell transplant［J］. Bone Marrow Transplant， 2020， 55（2）： 332-340. |
| 69 | SANLI H， AKAY B N， ARAT M， et al. Vitiligo after hematopoietic cell transplantation： six cases and review of the literature［J］. Dermatology， 2008， 216（4）： 349-354. |
| [1] | SI Henan, ZHONG Shuxia, ZHOU Junfeng, YAO Lei, LIU Yuanyuan, SONG Yang, LI Shanshan. Analysis on clinical characteristics and risk factors of 271 children with vitiligo [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 147-150. |
| [2] | ZHOU Ming-Wei, JIANG Ri-Hua, ZHANG Qi. Therapeutic effect of glycyrrhiza active substance on guinea pig model of vitiligo [J]. J4, 2009, 35(5): 852-856. |
| [3] | . Evaluation on curative effect of autologous melanocyte transplantation in treatment of |patients |withdifferent clinical types of |vitiligo [J]. J4, 2012, 38(6): 1187-1190. |
|
